Ivermectin induces nonprotective autophagy by downregulating PAK1 and apoptosis in lung adenocarcinoma cells

• Published in: Cancer chemotherapy and pharmacology 2024, Vol.93 (1), p.41-54
• Main Authors: Li, Man-Yuan, Zhang, Jiao, Lu, Xiao, Zhou, Dong, Deng, Xu-Feng, Liu, Quan-Xing, Dai, Ji-Gang, Zheng, Hong
• Format: Article
• Language: English
• Subjects: Adenocarcinoma; Adenocarcinoma of Lung - drug therapy; Adenocarcinoma of Lung - pathology; Animals; Annexin V; Anticancer properties; Antiparasitic agents; Antitumor activity; Antiviral drugs; Apoptosis; Autophagy; Avermectin; Cancer; Cancer Research; Cell Proliferation; Cell viability; Cholecystokinin; Flow cytometry; Humans; Immunohistochemistry; Ivermectin; Ivermectin - pharmacology; Lung cancer; Lung carcinoma; Lung Neoplasms - pathology; Lungs; Medicine; Medicine & Public Health; Mice; Mice, Nude; Mortality; Oncology; Original Article; p21-Activated Kinases - genetics; p21-Activated Kinases - metabolism; p21-Activated Kinases - pharmacology; Pharmacology/Toxicology; Staining; Veterinary medicine; Western blotting; Xenografts; Xenotransplantation
• ISSN: 0344-5704; 1432-0843
• DOI: 10.1007/s00280-023-04589-6

Introduction LUAD (Lung adenocarcinoma), the most common subtype of lung carcinoma and one of the highest incidences and mortality cancers in the world remains still a substantial treatment challenge. Ivermectin, an avermectin derivative, has been traditionally used as an antiparasitic agent in human and veterinary medicine practice during the last few decades. Though ivermectin has been shown to be effective against a variety of cancers, however, there is few available data reporting the antitumor effects of ivermectin in LUAD. Methods The effect of ivermectin on cell viability and proliferative ability of LUAD cells was evaluated using CCK-8 and colony formation assay. Apoptosis rate and autophagy flux were detected using flow cytometry based on PI/Annexin V staining and confocal laser scanning microscope based on LC3-GFP/RFP puncta, respectively. Western blotting experiment was conducted to verify the results of changes in apoptosis and autophagy. LUAD-TCGA and GEO databases were used to analyse the expression and predictive value of PAK1 in LUAD patients. Xenograft model and immumohistochemical staining were used for verification of the inhibitor effect of ivermectin in vivo. Results Ivermectin treatment strikingly impeded the colony formation, and the viability of the cell, along with cell proliferation, and caused the apoptosis and enhanced autophagy flux in LUAD cells. In addition, ivermectin-induced nonprotective autophagy was confirmed by treating LUAD cells with 3-MA, an autophagy inhibitor. Mechanistically, we found that ivermectin inhibited PAK1 protein expression in LUAD cells and we confirmed that overexpression of PAK1 substantially inhibited ivermectin-induced autophagy in LUAD cells. Based on TCGA and GEO databases, PAK1 was highly expressed in LUAD tissues as compared with normal tissues. Furthermore, LUAD patients with high PAK1 level have poor overall survival. Finally, in vivo experiments revealed that ivermectin efficiently suppressed the cellular growth of LUAD among nude mice. Conclusion This study not only revealed the mechanism of ivermectin inhibited the growth of LUAD but also supported an important theoretical basis for the development of ivermectin during the therapy for LUAD.